Extreme laser pulse-energy measurements by means of photon momentum.

Extreme lasers capable of short, high-energy pulses are probing the frontiers of science and advancing practical technology. The utility of such lasers increases with their average power delivery, which enables faster data acquisition, higher flux of laser-driven particle and radiation sources and more efficient material processing. However, the same extreme energies and electric field strengths of these lasers are currently preventing their direct and high accuracy measurement for these experimental applications.

High amplification laser-pressure optic enables ultra-low uncertainty measurements of the optical laser power at kilowatt levels.

We present the first measurements of kilowatt laser power with an uncertainty less than 1 %. These represent progress toward the most accurate measurements of laser power above 1 kW at 1070 nm wavelength and establish a more precise link between force metrology and laser power metrology. Radiation pressure, or photon momentum, is a relatively new method of non-destructively measuring laser power.

Simplified kilogram traceability for high-power laser measurement using photon momentum radiometers.

Photon momentum radiometers measure the force imparted by a reflected laser beam to determine the laser's optical power. This requires high-accuracy calibration of the force sensors using milligram and microgram mass artifacts. Calibrated test masses can therefore be used to provide traceability of these radiometers to the International System of Units, but low-noise calibration at these mass levels is difficult.

Selective Deoxygenation of Biomass-Derived Bio-oils within Hydrogen-Modest Environments: A Review and New Insights.

Research development of processes for refining bio-oils is becoming increasingly popular. One issue that these processes possess is their high requirement for H2 gas. In response, researchers must develop catalysts that perform deoxygenation while minimizing H2 consumption-selective deoxygenation.

Expression of aldo-keto reductase family 1 member C3 (AKR1C3) in neuroendocrine tumors & adenocarcinomas of pancreas, gastrointestinal tract, and lung.

Human aldo-keto reductase family 1 member C3 (AKR1C3) was initially identified as an enzyme in reducing 5α-dihydrotestosterone (5α-DHT) to 5α-androstane-3α, 17β-diol (3α-diol) and oxidizing 3α-diol to androsterone. It was subsequently demonstrated to possess ketosteroid reductase activity in metabolizing other steroids including estrogen and progesterone, 11-ketoprostaglandin reductase activity in metabolizing prostaglandins, and dihydrodiol dehydrogenase x (DDx) activity in metabolizing xenobiotics. AKR1C3 was demonstrated in sex hormone-dependent tissues including testis, breast, endometrium, and prostate; in sex hormone-independent tissues including kidney and urothelium.